MannKind Corp
MNKD
$4.05
Share price
1.00%
Change (1 day)
-1.22%
Change (1 year)
Categories
MannKind Corp (MNKD) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $0.57 B
According to MannKind Corp's latest financial reports the company's total liabilities are $0.57 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
MannKind Corp - Total liabilities on balance sheet (from 2004 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.54 B | 2.89% |
| 2021-12-31 | $0.53 B | 83.55% |
| 2020-12-31 | $0.28 B | 1.68% |
| 2019-12-31 | $0.28 B | 0.52% |
| 2018-12-31 | $0.28 B | -5.52% |
| 2017-12-31 | $0.29 B | 2.98% |
| 2016-12-31 | $0.29 B | -39.03% |
| 2015-12-31 | $0.47 B | 1.82% |
| 2014-12-31 | $0.46 B | 61.81% |
| 2013-12-31 | $0.28 B | -20.07% |
| 2012-12-31 | $0.36 B | -29.46% |
| 2011-12-31 | $0.51 B | 10.89% |
| 2010-12-31 | $0.46 B | 50.93% |
| 2009-12-31 | $0.30 B | 56.66% |
| 2008-12-31 | $0.19 B | 9.13% |
| 2007-12-31 | $0.17 B | 14.78% |
| 2006-12-31 | $0.15 B | 630.34% |
| 2005-12-31 | $21.39 M | 63.06% |
| 2004-12-31 | $13.12 M | -8.25% |
| 2003-12-31 | $14.29 M | 2.14% |
| 2002-12-31 | $14 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $94.38 B | 16,345.29% | 🇺🇸 USA |
 Novo Nordisk NVO | $27.77 B | 4,738.89% | 🇩🇰 Denmark |
 Eli Lilly LLY | $43.66 B | 7,508.30% | 🇺🇸 USA |
 Merck MRK | $60.89 B | 10,509.87% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $1.65 B | 189.14% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $0.29 B | -48.19% | 🇺🇸 USA |